Articles from Tekla Healthcare Opportunities Fund

On October 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is October 20, 2023 and the payable date is October 31, 2023. The Fund will trade ex-distribution on October 19, 2023.

On September 29, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and net realized long-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $116,499,588 of which $60,090,063 represents net unrealized appreciation of portfolio securities.

On September 11, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is September 21, 2023 and the payable date is September 29, 2023. The Fund will trade ex-distribution on September 20, 2023.

On August 31, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $140,065,326 of which $89,356,276 represents net unrealized appreciation of portfolio securities.

On August 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is August 21, 2023 and the payable date is August 31, 2023. The Fund will trade ex-distribution on August 18, 2023.

Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $164,957,160, of which $134,138,010 represents net unrealized appreciation of portfolio securities.

On July 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is July 20, 2023 and the payable date is July 31, 2023. The Fund will trade ex-distribution on July 19, 2023.

On June 30, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $134,720,424 of which $123,370,159 represents net unrealized appreciation of portfolio securities.

On June 9, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is June 20, 2023 and the payable date is June 30, 2023. The Fund will trade ex-distribution on June 16, 2023.

On May 31, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $111,909,121 of which $98,070,008 represents net unrealized appreciation of portfolio securities.

On May 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is May 22, 2023 and the payable date is May 31, 2023. The Fund will trade ex-distribution on May 19, 2023.

On April 28, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $138,400,650 of which $129,447,305 represents net unrealized appreciation of portfolio securities.

On April 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is April 20, 2023 and the payable date is April 28, 2023. The Fund will trade ex-distribution on April 19, 2023.

On March 31, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $92,230,970, of which $85,549,742 represents net unrealized appreciation of portfolio securities.

Tekla Healthcare Opportunities Fund (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2023. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year-period ending July 14, 2024. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund’s shares and the net asset value per share. The share repurchase program is intended to increase the Fund’s net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares.

On March 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is March 20, 2023 and the payable date is March 31, 2023. The Fund will trade ex-distribution on March 17, 2023.

On February 28, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $114,076,680 of which $108,380,701 represents net unrealized appreciation of portfolio securities.

On February 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is February 21, 2023 and the payable date is February 28, 2023. The Fund will trade ex-distribution on February 17, 2023.

On January 31, 2023, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $146,155,208 of which $143,877,972 represents net unrealized appreciation of portfolio securities.

On January 10, 2023, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is January 20, 2023 and the payable date is January 31, 2023. The Fund will trade ex-distribution on January 19, 2023.

On December 30, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $137,650,758 of which $136,207,583 represents net unrealized appreciation of portfolio securities.

On December 9, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is December 19, 2022 and the payable date is December 30, 2022. The Fund will trade ex-distribution on December 16, 2022.

On November 30, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $133,538,418 of which $133,070,649 represents net unrealized appreciation of portfolio securities.

On November 10, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is November 21, 2022 and the payable date is November 30, 2022. The Fund will trade ex-distribution on November 18, 2022.

On October 31, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $94,535,800 of which $93,961,010 represents net unrealized appreciation of portfolio securities.

On October 10, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is October 20, 2022 and the payable date is October 31, 2022. The Fund will trade ex-distribution on October 19, 2022.

On September 30, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $116,193,094 of which $67,733,180 represents net unrealized appreciation of portfolio securities.

On September 9, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is September 20, 2022 and the payable date is September 30, 2022. The Fund will trade ex-distribution on September 19, 2022.

On August 31, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $157,271,254 of which $138,871,488 represents net unrealized appreciation of portfolio securities.

On July 29, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $167,373,327 of which $151,795,174 represents net unrealized appreciation of portfolio securities.

On July 11, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is July 21, 2022 and the payable date is July 29, 2022. The Fund will trade ex-distribution on July 20, 2022.

On June 30, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $130,397,209, of which $113,214,308 represents net unrealized appreciation of portfolio securities.

On June 10, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is June 21, 2022 and the payable date is June 30, 2022. The Fund will trade ex-distribution on June 17, 2022.

Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $163,578,443, of which $146,439,817 represents net unrealized appreciation of portfolio securities.

On May 10, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is May 20, 2022 and the payable date is May 31, 2022. The Fund will trade ex-distribution on May 19, 2022.

On April 29, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $201,887,546, of which $184,036,615 represents net unrealized appreciation of portfolio securities.

On April 11, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is April 21, 2022 and the payable date is April 29, 2022. The Fund will trade ex-distribution on April 20, 2022.

On March 31, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $201,420,835, of which $192,752,811 represents net unrealized appreciation of portfolio securities.

Tekla Healthcare Opportunities Fund (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2022. The renewal will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year-period ending July 14, 2023. The Board authorized the share repurchase program as a result of its periodic review of the options available to enhance shareholder value and potentially reduce the discount between the market price of the Fund’s shares and the net asset value per share. The share repurchase program is intended to increase the Fund’s net asset value per share and could also have the benefit of providing additional liquidity in the trading of shares.

On February 28, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $153,742,419, of which $147,090,016 represents net unrealized appreciation of portfolio securities.

On February 8, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is February 18, 2022 and the payable date is February 28, 2022. The Fund will trade ex-distribution on February 17, 2022.

On January 31, 2022, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $156,998,295, of which $152,588,482 represents net unrealized appreciation of portfolio securities.

On January 10, 2022, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is January 20, 2022 and the payable date is January 31, 2022. The Fund will trade ex-distribution on January 19, 2022.

On December 31, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $252,118,815, of which $248,098,171 represents net unrealized appreciation of portfolio securities.

On December 10, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is December 20, 2021 and the payable date is December 31, 2021. The Fund will trade ex-distribution on December 17, 2021.

On November 30, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $214,243,594, of which $211,404,134 represents net unrealized appreciation of portfolio securities.

On November 9, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is November 19, 2021 and the payable date is November 30, 2021. The Fund will trade ex-distribution on November 18, 2021.

On October 29, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains and net realized long-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $220,164,998, of which $219,011,623 represents net unrealized appreciation of portfolio securities.

On October 8, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is October 20, 2021 and the payable date is October 29, 2021. The Fund will trade ex-distribution on October 19, 2021.

On September 30, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains and net realized long-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $273,569,505, of which $214,670,945 represents net unrealized appreciation of portfolio securities.

On September 10, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is September 20, 2021 and the payable date is September 30, 2021. The Fund will trade ex-distribution on September 17, 2021.

On August 31, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $290,668,200, of which $243,042,122 represents net unrealized appreciation of portfolio securities.

On August 10, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is August 20, 2021 and the payable date is August 31, 2021. The Fund will trade ex-distribution on August 19, 2021.

On July 30, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains and net realized long-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $275,319,267, of which $230,589,954 represents net unrealized appreciation of portfolio securities.

On July 9, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is July 20, 2021 and the payable date is July 30, 2021. The Fund will trade ex-distribution on July 19, 2021.

On June 30, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains and net realized long-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $233,768,901, of which $191,726,381 represents net unrealized appreciation of portfolio securities.

On June 8, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is June 18, 2021 and the payable date is June 30, 2021. The Fund will trade ex-distribution on June 17, 2021.

On May 28, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net investment income, net realized short-term capital gains, net realized long-term capital gains and return of capital or other capital source. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $225,244,006, of which $185,933,532 represents net unrealized appreciation of portfolio securities.

On May 10, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is May 20, 2021 and the payable date is May 28, 2021. The Fund will trade ex-distribution on May 19, 2021.

On April 30, 2021, Tekla Healthcare Opportunities Fund paid a monthly distribution of $0.1125 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains. The composition of this and subsequent distributions may vary from month to month because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale of securities is $226,306,147, of which $199,527,793 represents net unrealized appreciation of portfolio securities.

On April 9, 2021, Tekla Healthcare Opportunities Fund declared its monthly cash distribution of $0.1125 per share. The record date for the monthly cash distribution is April 20, 2021 and the payable date is April 30, 2021. The Fund will trade ex-distribution on April 19, 2021.